Myeloid derived suppressor cells and their role in tolerance induction in cancer
- PMID: 20570112
- DOI: 10.1016/j.jdermsci.2010.05.001
Myeloid derived suppressor cells and their role in tolerance induction in cancer
Abstract
Myeloid derived suppressor cells (MDSCs) comprise a phenotypically heterogeneous population of cells, which can be found in tumor-bearing mice and in patients with cancer. MDSCs play a central role in the induction of peripheral tolerance. Together with regulatory T cells (Tregs) they promote an immunosuppressive environment in tumor-bearing hosts. The phenotype of MDSCs differs in humans and mice, and the exact mechanisms of their suppressive function are still controversially discussed. In summary, MDSCs are a group of phenotypically heterogeneous cells of myeloid origin that have common biological activities. In this review, we discuss the definition of MDSCs, the proposed mechanisms of expansion and the recruitment and activation of MDSCs, as well as their biological activities in tumorbearing hosts to assess the potential therapeutic applications.
Similar articles
-
Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.J Immunol. 2012 Dec 15;189(12):5602-11. doi: 10.4049/jimmunol.1201018. Epub 2012 Nov 14. J Immunol. 2012. PMID: 23152559
-
Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.Gastroenterology. 2008 Sep;135(3):871-81, 881.e1-5. doi: 10.1053/j.gastro.2008.06.032. Epub 2008 Jun 12. Gastroenterology. 2008. PMID: 18674538
-
Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.J Genet Genomics. 2010 Jul;37(7):423-30. doi: 10.1016/S1673-8527(09)60061-8. J Genet Genomics. 2010. PMID: 20659706
-
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x. Immunol Rev. 2008. PMID: 18364001 Review.
-
Antigen specificity of immune suppression by myeloid-derived suppressor cells.J Leukoc Biol. 2011 Jul;90(1):31-6. doi: 10.1189/jlb.0111021. Epub 2011 Apr 12. J Leukoc Biol. 2011. PMID: 21486906 Review.
Cited by
-
Current Status and Molecular Mechanisms of Resistance to Immunotherapy in Oral Malignant Melanoma.Int J Mol Sci. 2023 Dec 8;24(24):17282. doi: 10.3390/ijms242417282. Int J Mol Sci. 2023. PMID: 38139110 Free PMC article. Review.
-
Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice.Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):3. doi: 10.1167/iovs.62.7.3. Invest Ophthalmol Vis Sci. 2021. PMID: 34061951 Free PMC article.
-
Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate.Case Rep Dermatol. 2012 Jan;4(1):5-9. doi: 10.1159/000335999. Epub 2012 Jan 11. Case Rep Dermatol. 2012. PMID: 22308113 Free PMC article.
-
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?J Clin Med. 2020 Mar 28;9(4):930. doi: 10.3390/jcm9040930. J Clin Med. 2020. PMID: 32231117 Free PMC article. Review.
-
Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance.Int J Mol Sci. 2023 May 25;24(11):9279. doi: 10.3390/ijms24119279. Int J Mol Sci. 2023. PMID: 37298230 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources